A brief application for a new drug for Lochatan potassium tablets filed by Haizheng Pharmaceuticals to the U.S. FDA has been approved

recently, Haizheng Pharmaceuticals announced that the
holding company(http://Haizheng Pharmaceutical (Hangzhou) Co., Ltd("Haizheng Hangzhou Company") received a notice from the U.SFoodMedicines(http://Regulatory Authority (hereinafter referred to as the "U.SFDA(http://" notice, Haizheng Hangzhou The Company'sNew Drug(http://Application for theof The Loshatan Potassium Tablets filed with the U.SFDA, which is a u.S Pharmaceutical (http:// , and the application for FDA approval means that the applicant can produce and sell the product (http:// ) in the U.S market 　　About Losatan potassium tablets
Losatan potassium tablets are mainly suitable for the treatment of hypertension, type 2 diabetes kidney disease Cozaar, the original research drug, was developed by Merck, and domestic and foreign manufacturers are mainly Zhejiang Huahai Pharmaceutical Co., Ltd., China Resources Shuanghe Pharmaceutical Co., Ltd., Beijing Shuangji Pharmaceutical Co., Ltd 　　So far, Haizheng Pharmaceuticals has invested about 6.8 million yuan in the drug research and development project The approval of the Losatan potash tablet ANDA by the U.S FDA marks the company's eligibility to sell the product in the U.S market, which has a positive impact on the company's expansion into the U.S market